pI: 6.7299 |
Length (AA): 327 |
MW (Da): 37213 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 3 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
1 | 327 | 4u1e (I) | 1 | 332 | 33.00 | 0 | 1 | 1.3294 | -0.27 |
6 | 84 | 4wjs (A) | 400 | 479 | 34.00 | 0.0052 | 0.99 | 0.72999 | -0.67 |
246 | 315 | 4zoy (A) | 79 | 167 | 40.00 | 0.091 | 0.26 | 0.362467 | 1.2 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | 4 hs Ring, 16 hs Trophozoite, Erthyrocytic stages. | Otto TD Yeoh LM |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | Ookinete, Female gametocyte, Male gametocyte. | Otto TD Yeoh LM |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | Gametocyte, 22 hs Schizont. | Otto TD |
Yeoh LM | Comparative transcriptomics of female and male gametocytes in Plasmodium berghei and the evolution of sex in alveolates. |
Otto TD | A comprehensive evaluation of rodent malaria parasite genomes and gene expression. |
Ortholog group members (OG5_127718)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT2G46290 | transducin/WD40 repeat-like superfamily protein |
Arabidopsis thaliana | AT2G46280 | TGF-beta receptor interacting protein 1 |
Babesia bovis | BBOV_IV003330 | translation initiation factor 3 subunit 2 |
Brugia malayi | Bm1_48300 | Eukaryotic initiation factor protein 3.I |
Candida albicans | CaO19.2967 | similar to S. cerevisiae TIF34 (YMR146C) translation initiation factor eIF3 p39 subunit |
Candida albicans | CaO19.10484 | similar to S. cerevisiae TIF34 (YMR146C) translation initiation factor eIF3 p39 subunit |
Caenorhabditis elegans | CELE_Y74C10AR.1 | Protein EIF-3.I |
Cryptosporidium hominis | Chro.50323 | eukaryotic translation initiation factor 3 37.28 kDa subunit |
Cryptosporidium parvum | cgd5_680 | eukaryotic translation initiation factor 3 37.28 kDa subunit, putative |
Dictyostelium discoideum | DDB_G0285683 | WD40 repeat-containing protein |
Drosophila melanogaster | Dmel_CG8882 | CG8882 gene product from transcript CG8882-RA |
Echinococcus granulosus | EgrG_000297200 | eukaryotic translation initiation factor 3 |
Entamoeba histolytica | EHI_118720 | WD domain containing protein |
Echinococcus multilocularis | EmuJ_000297200 | eukaryotic translation initiation factor 3 |
Giardia lamblia | GL50803_13661 | Eukaryotic translation initiation factor 3 subunit 2 |
Homo sapiens | ENSG00000084623 | eukaryotic translation initiation factor 3, subunit I |
Leishmania braziliensis | LbrM.35.4110 | eukaryotic translation initiation factor 3 subunit, putative |
Leishmania donovani | LdBPK_364070.1 | eukaryotic translation initiation factor 3 subunit, putative |
Leishmania infantum | LinJ.36.4070 | eukaryotic translation initiation factor 3 subunit, putative |
Leishmania major | LmjF.36.3880 | eukaryotic translation initiation factor 3 subunit, putative |
Leishmania mexicana | LmxM.36.3880 | eukaryotic translation initiation factor 3 subunit, putative |
Loa Loa (eye worm) | LOAG_08550 | eukaryotic initiation factor protein 3.I |
Mus musculus | ENSMUSG00000028798 | eukaryotic translation initiation factor 3, subunit I |
Neospora caninum | NCLIV_042070 | hypothetical protein |
Oryza sativa | 4338229 | Os05g0256000 |
Oryza sativa | 4345234 | Os08g0308100 |
Plasmodium berghei | PBANKA_0614500 | eukaryotic translation initiation factor 3 subunit I, putative |
Plasmodium falciparum | PF3D7_0716800 | eukaryotic translation initiation factor 3 subunit I, putative |
Plasmodium knowlesi | PKNH_0311600 | eukaryotic translation initiation factor 3 subunit I, putative |
Plasmodium vivax | PVX_000590 | eukaryotic translation initiation factor 3 subunit 2, putative |
Plasmodium yoelii | PY00595 | eukaryotic translation initiation factor 3 39 kDa subunit |
Saccharomyces cerevisiae | YMR146C | translation initiation factor eIF3 subunit I |
Schistosoma japonicum | Sjp_0015700 | ko:K03246 translation initiation factor eIF-3 subunit 2, putative |
Schistosoma mansoni | Smp_006000 | eukaryotictranslation initiation factor 3 subunit |
Schmidtea mediterranea | mk4.003687.03 | Eukaryotic translation initiation factor 3 subunit I |
Trypanosoma brucei gambiense | Tbg972.11.10790 | eukaryotic translation initiation factor 3 subunit, putative,TGF-beta receptor interacting protein 1 |
Trypanosoma brucei | Tb927.11.9610 | eukaryotic translation initiation factor 3 subunit i |
Trypanosoma congolense | TcIL3000.11.10110 | eukaryotic translation initiation factor 3 subunit i |
Trypanosoma congolense | TcIL3000_0_20520 | eukaryotic translation initiation factor 3 subunit 2, putative |
Trypanosoma cruzi | TcCLB.511589.230 | eukaryotic translation initiation factor 3 subunit 2, putative |
Trypanosoma cruzi | TcCLB.511229.80 | eukaryotic translation initiation factor 3 subunit i |
Toxoplasma gondii | TGME49_289830 | eukaryotic initiation factor-3, delta subunit, putative |
Theileria parva | TP01_1092 | eukaryotic translation initiation factor 3 subunit 2, putative |
Trichomonas vaginalis | TVAG_114460 | eukaryotic translation initiation factor 3 subunit, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb11.01.1370 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb11.01.1370 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb11.01.1370 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb11.01.1370 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_Y74C10AR.1 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_Y74C10AR.1 | Caenorhabditis elegans | slow growth | wormbase |
CELE_Y74C10AR.1 | Caenorhabditis elegans | sterile | wormbase |
YMR146C | Saccharomyces cerevisiae | inviable | yeastgenome |
PBANKA_0614500 this record | Plasmodium berghei | Essential | plasmo |
TGME49_289830 | Toxoplasma gondii | Probably essential | sidik |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.